202 related articles for article (PubMed ID: 23482657)
1. Regional variation in spending and survival for older adults with advanced cancer.
Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D
J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657
[TBL] [Abstract][Full Text] [Related]
2. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer.
Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP
Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176
[TBL] [Abstract][Full Text] [Related]
3. Area-level variations in cancer care and outcomes.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
[TBL] [Abstract][Full Text] [Related]
4. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
5. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
[TBL] [Abstract][Full Text] [Related]
6. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
Landrum MB; Keating NL; Lamont EB; Bozeman SR; Krasnow SH; Shulman L; Brown JR; Earle CC; Rabin M; McNeil BJ
J Clin Oncol; 2012 Apr; 30(10):1072-9. PubMed ID: 22393093
[TBL] [Abstract][Full Text] [Related]
7. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
Chen CT; Li L; Brooks G; Hassett M; Schrag D
Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
[TBL] [Abstract][Full Text] [Related]
8. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
9. Regional Medicare Expenditures and Survival Among Older Women With Localized Breast Cancer.
Tannenbaum S; Soulos PR; Herrin J; Mougalian S; Long JB; Wang R; Ma X; Gross CP; Xu X
Med Care; 2017 Dec; 55(12):1030-1038. PubMed ID: 29068906
[TBL] [Abstract][Full Text] [Related]
10. Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapies.
Youn B; Wilson IB; Mor V; Trikalinos NA; Dahabreh IJ
Health Serv Res; 2021 Jun; 56(3):486-496. PubMed ID: 33682120
[TBL] [Abstract][Full Text] [Related]
11. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?
Koroukian SM; Bakaki PM; Owusu C; Earle CC; Cooper GS
Medicare Medicaid Res Rev; 2012; 2(2):. PubMed ID: 24800139
[TBL] [Abstract][Full Text] [Related]
12. Estimating the cost of cancer care in the United States: a work very much in progress.
Lipscomb J
J Natl Cancer Inst; 2008 May; 100(9):607-10. PubMed ID: 18445816
[No Abstract] [Full Text] [Related]
13. Regional variation in the association between advance directives and end-of-life Medicare expenditures.
Nicholas LH; Langa KM; Iwashyna TJ; Weir DR
JAMA; 2011 Oct; 306(13):1447-53. PubMed ID: 21972306
[TBL] [Abstract][Full Text] [Related]
14. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.
Hassett MJ; Banegas M; Uno H; Weng S; Cronin AM; O'Keeffe Rosetti M; Carroll NM; Hornbrook MC; Ritzwoller DP
J Oncol Pract; 2019 Jul; 15(7):e616-e627. PubMed ID: 31107629
[TBL] [Abstract][Full Text] [Related]
15. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.
Fisher ES; Wennberg DE; Stukel TA; Gottlieb DJ; Lucas FL; Pinder EL
Ann Intern Med; 2003 Feb; 138(4):273-87. PubMed ID: 12585825
[TBL] [Abstract][Full Text] [Related]
16. Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer.
Brooks GA; Li L; Uno H; Hassett MJ; Landon BE; Schrag D
Health Aff (Millwood); 2014 Oct; 33(10):1793-800. PubMed ID: 25288424
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
18. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
[TBL] [Abstract][Full Text] [Related]
19. Cost variation and savings opportunities in the Oncology Care Model.
Baumgardner J; Shahabi A; Zacker C; Lakdawalla D
Am J Manag Care; 2018 Dec; 24(12):618-623. PubMed ID: 30586495
[TBL] [Abstract][Full Text] [Related]
20. The association of hospital spending intensity and cancer outcomes: a population-based study in an Asian country.
Chang TS; Huang KY; Chang CM; Lin CH; Su YC; Lee CC
Oncologist; 2014 Sep; 19(9):990-8. PubMed ID: 25117067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
